参考文献/References:
[1]TURPIN J, LYNCH DG, WHITE T, et al. Hyperperfusion syndrome after superficial temporal artery-middle cerebral artery bypass for non-moyamoya steno-occlusive disease[J]. J Stroke Cerebrovasc Dis, 2023, 2(8): 107222.
[2]YU J, ZHANG J, LI J, et al. Cerebral hyperperfusion syndrome after revascularization surgery in patients with moyamoya disease: systematic review and meta-analysis[J]. World Neurosurg, 2020, 135: 357-66.e4.
[3]ISHIKAWA T, YAMAGUCHI K, KAWASHIMA A, et al. Predicting the occurrence of hemorrhagic cerebral hyperperfusion syndrome using regional cerebral blood flow after direct bypass surgery in patients with moyamoya disease[J]. World Neurosurg, 2018, 119: e750-e756.
[4]UCHINO H, KURODA S, HIRATA K, et al. Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/ positron emission tomography study[J]. Stroke, 2012, 43(10): 2610-2616.
[5]KAZUMATA K, UCHINO H, TOKAIRIN K, et al. Cerebral hyper-perfusion syndrome after revascularization surgery in moyamoya disease: region-symptom mapping and estimating a critical thres-hold[J]. World Neurosurg, 2018, 114: e388-e395.
[6]YANG T, HIGASHINO Y, KATAOKA H, et al. Correlation between reduction in microvascular transit time after superficial temporal artery-middle cerebral artery bypass surgery for moyamoya disease and the development of postoperative hyperperfusion syndrome[J]. J Neurosurg, 2018, 128(5): 1304-1310.
[7]ZHANG J, LI S, FUJIMURA M, et al. Hemodynamic analysis of the recipient parasylvian cortical arteries for predicting postoperative hyperperfusion during STA-MCA bypass in adult patients with moyamoya disease[J]. J Neurosurg, 2019, 134(1): 17-24.
[8]HWANG JW, YANG HM, LEE H, et al. Predictive factors of symp-tomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in adult patients with moyamoya disease[J]. Br J Anaesth, 2013, 110(5): 773-779.
[9]ZHAO M, DENG X, ZHANG D, et al. Risk factors for and outcomes of postoperative complications in adult patients with moyamoya disease[J]. J Neurosurg, 2018, 130(2): 531-542.
[10]TASHIRO R, FUJIMURA M, KATSUKI M, et al. Prolonged/delayed cerebral hyperperfusion in adult patients with moyamoya disease with RNF213 gene polymorphism c.14576G>A (rs112735431) after superficial temporal artery-middle cerebral artery anastomosis[J]. J Neurosurg, 2020, 135(2): 417-424.
[11]JO WY, OH H, KIM H, et al. Preoperative platelet count may predict postoperative symptomatic cerebral hyperperfusion syndrome after superficial temporal artery-middle cerebral artery anastomosis in moyamoya patients[J]. Clin Neurol Neurosurg, 2020, 199: 106260.
[12]YOON HK, OH H, LEE HC, et al. Effect of sevoflurane postconditioning on the incidence of symptomatic cerebral hyperperfusion after revascularization surgery in adult patients with moyamoya disease[J]. World Neurosurg, 2020, 134: e991-e1000.
[13]FUJIMURA M, NIIZUMA K, INOUE T, et al. Minocycline prevents focal neurological deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease[J]. Neuro-surgery, 2014, 74(2): 163-170.
[14]HORIE N, FUKUDA Y, IZUMO T, et al. Indocyanine green video-angiography for assessment of postoperative hyperperfusion in moyamoya disease[J]. Acta Neurochir (Wien), 2014, 156(5): 919-926.
[15]HU M, ZENG X, SU K, et al. Matching selection of donor-recipient vessels in revascularization surgery effectively reduce the incidence of postoperative hyperperfusion syndrome in adult moyamoya disease: a retrospective comparison study[J]. Cerebrovasc Dis, 2020, 49(4): 361-368.
[16]KAKU Y, IIHARA K, NAKAJIMA N, et al. Cerebral blood flow and metabolism of hyperperfusion after cerebral revascularization in patients with moyamoya disease[J]. J Cereb Blood Flow Metab, 2012, 32(11): 2066-2075.
[17]YANG D, ZHANG X, TAN C, et al. Intraoperative transit-time ultrasonography combined with FLOW800 predicts the occurrence of cerebral hyperperfusion syndrome after direct revascularization of Moyamoya disease: a preliminary study[J]. Acta Neurochir (Wien), 2021, 163(2): 563-571.
[18]KATSUKI M, FUJIMURA M, TASHIRO R, et al. Pre-operative higher hematocrit and lower total protein levels are independent risk factors for cerebral hyperperfusion syndrome after superficial temporal artery-middle cerebral artery anastomosis with pial synan-giosis in adult moyamoya disease patients-case-control study[J]. Neurosurg Rev, 2021, 44(4): 2191-200.
[19]HORIE N, MORIKAWA M, MOROFUJI Y, et al. De novo ivy sign indicates postoperative hyperperfusion in moyamoya disease[J]. Stroke, 2014, 45(5): 1488-1491.
相似文献/References:
[1]李 琴 袁辉胜.高压氧治疗抢救烟雾病合并一氧化碳中毒1例[J].中国临床神经外科杂志,2016,(07):441.[doi:10.13798/j.issn.1009-153X.2016.07.019]
[2]张登文 邓剑平 张 涛 陈 虎 赵振伟.颞浅动脉-颞浅筋膜-脑贴敷术治疗烟雾病疗效观察[J].中国临床神经外科杂志,2015,(06):326.[doi:10.13798/j.issn.1009-153X.2015.06.002]
ZHANG Deng-wen,DENG Jian-ping,ZHANG Tao,et al.Curative effect of encephalo-superficial temporal artery-superficial temporal fascia flap-synangiosis on Moyamoya disease (report of 31 cases)[J].,2015,(08):326.[doi:10.13798/j.issn.1009-153X.2015.06.002]
[3]刘锡禹 张正善 赵 峰 韩 聪 李 斌 段 炼.烟雾病合并后循环病变致继发枕叶梗死的相关危险因素分析[J].中国临床神经外科杂志,2015,(07):392.[doi:10.13798/j.issn.1009-153X.2015.07.003]
LIU Xi-yu,ZHANG Zheng-shan,ZHAO Feng,et al.Analysis of the risk factors related to occipital lobe infarction induced by Moyamoya disease complicated with posterior circulation lesions[J].,2015,(08):392.[doi:10.13798/j.issn.1009-153X.2015.07.003]
[4]黄 坦 黄书岚 陈谦学.颞浅动脉-大脑中动脉搭桥术治疗成人烟雾病[J].中国临床神经外科杂志,2015,(05):271.[doi:10.13798/j.issn.1009-153X.2015.05.005]
HUANG Tan,HUANG Shu-lan,CHEN Qian-xue..Treatment of Moyamoya disease with superficial temporal artery-middle cerebral artery bypass in adults[J].,2015,(08):271.[doi:10.13798/j.issn.1009-153X.2015.05.005]
[5]李 舜 唐晓平 文 军 罗仁国 张 柳 段军伟 彭 华 赵 龙.成人出血型烟雾病合并颅内动脉瘤的诊治及预后分析[J].中国临床神经外科杂志,2017,(04):213.[doi:10.13798/j.issn.1009-153X.2017.04.002]
LI Shun,TANG Xiao-ping,WEN Jun,et al.Diagnosis, treatment and prognosis of intracranial aneurysms in adults with hemorrhagic moyamoya disease[J].,2017,(08):213.[doi:10.13798/j.issn.1009-153X.2017.04.002]
[6]马廉亭.建议把“烟雾病”诊断还原为“脑基底异常血管网”症[J].中国临床神经外科杂志,2017,(07):449.[doi:10.13798/j.issn.1009-153X.2017.07.001]
[7]陈姣红 刘东媛 张红波 李明昌 熊晓星 陈谦学.成人出血型烟雾病围手术期护理观察[J].中国临床神经外科杂志,2018,(06):437.[doi:10.13798/j.issn.1009-153X.2018.06.020]
[8]杨允东 李永强.多普勒超声血流动力学监测在烟雾病STA-MCA吻合术中的应用[J].中国临床神经外科杂志,2018,(07):476.[doi:10.13798/j.issn.1009-153X.2018.07.008]
YANG Yun-dong,LI Yong-qiang..Change in the STA hymodynamics monitored by color Doppler ultrasound before and after STA-MCA anastomosis in patients with Moyamoya disease[J].,2018,(08):476.[doi:10.13798/j.issn.1009-153X.2018.07.008]
[9]欧阳光 黄书岚.烟雾病的现况及研究进展[J].中国临床神经外科杂志,2018,(08):564.[doi:doi:10.13798/j.issn.1009-153X.2018.08.020]
[10]黄彩菲,刘雅静,张红波,等.烟雾病血运重建术中配合及护理[J].中国临床神经外科杂志,2018,(10):692.[doi:10.13798/j.issn.1009-153X.2018.10.018]
[11]张华建,万蕾,罗先武,等.基于自我效能理论的有氧运动处方在脑底异常血管网症中的应用[J].中国临床神经外科杂志,2024,29(06):327.[doi:10.13798/j.issn.1009-153X.2024.06.002]
ZHANG Hua-jian,WAN Lei,LUO Xian-wu,et al.Application of aerobic exercise prescription based on self-efficacy theory in patients with moyamoya disease[J].,2024,29(08):327.[doi:10.13798/j.issn.1009-153X.2024.06.002]
[12]王浩,王晨潮,董阳,等.脑底异常血管网症合并颅内动脉瘤破裂风险评分系统的建立和验证[J].中国临床神经外科杂志,2024,29(06):332.[doi:10.13798/j.issn.1009-153X.2024.06.003]
WANG Hao,WANG Chen-chao,DONG Yang,et al.Establishment and validation of risk score for intracranial aneurysm rupture in patients with moyamoya disease[J].,2024,29(08):332.[doi:10.13798/j.issn.1009-153X.2024.06.003]